Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporary mechanical circulatory support in left ventricular assist device candidates with right ventricular dysfunction: Acuity without long-term futility.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Mobile endoscopy in rural South Africa: outcomes of a decentralised outreach programme to improve gastrointestinal healthcare access.

BMJ open gastroenterology·2025
Same author

Sex-specific outcomes after thoracic aortic surgery.

The Journal of thoracic and cardiovascular surgery·2025
Same author

Cerebral Venous Drainage Disorders: A Potential Missing Piece in Thoracic Outlet Syndrome.

Annals of vascular surgery·2025
Same author

Sternocleidomastoid Omohyoid Entrapment of the Internal Jugular Vein Causing Vertigo and Headaches.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2025
Same author

Persistent Oscillating Vertigo From Extracranial Venous Compression.

Otology & neurotology open·2025

Related Experiment Video

Updated: Jun 18, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.9K

Temporary Mechanical Circulatory Support in the Complex Vasculopath: Redefining What Is Possible.

Carly Lodewyks1, Joseph Karam2, Peter Eckman3

  • 1Allina Health Minneapolis Heart Institute Section of Cardiac Surgery, Minneapolis, Minnesota, USA.

JACC. Case Reports
|October 31, 2025
PubMed
Summary

Temporary mechanical circulatory support with Impella 5.5 enables complex procedures for patients with severe cardiomyopathy. This approach, combined with multidisciplinary care, improves outcomes for high-risk cardiovascular patients.

Keywords:
Impellaaneurysmaortic stenosiscardiomyopathy

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.3K

Related Experiment Videos

Last Updated: Jun 18, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.9K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.3K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Mechanical Circulatory Support

Background:

  • Severe cardiomyopathy presents significant challenges for complex cardiovascular interventions.
  • Traditional risk stratification often excludes patients with severe cardiomyopathy from advanced procedures.
  • Widespread vasculopathy further complicates management in these high-risk individuals.

Purpose of the Study:

  • To evaluate the utility of temporary mechanical circulatory support in managing complex vasculopathy.
  • To assess the feasibility of using Impella 5.5 in patients with severe cardiomyopathy undergoing major interventions.
  • To highlight the importance of a multidisciplinary approach in optimizing outcomes.

Main Methods:

  • A case report of a 64-year-old male with severe bicuspid aortic stenosis, coronary disease, cardiomyopathy, and widespread vascular disease.
  • The patient underwent aortic valve replacement with direct aortic Impella 5.5 support.
  • Subsequent procedures included Impella-supported percutaneous coronary intervention, carotid endarterectomy, and abdominal aortic aneurysm repair.

Main Results:

  • Successful implementation of Impella 5.5 for a complex, multi-stage cardiovascular intervention.
  • The patient tolerated multiple procedures, including aortic valve replacement and coronary intervention, under mechanical support.
  • Completion of all planned interventions, including vascular repairs, prior to discharge.

Conclusions:

  • Severe cardiomyopathy should not be considered a prohibitive risk for interventions with advanced mechanical circulatory support like Impella 5.5.
  • Impella 5.5 facilitates complex procedures in high-risk patients with combined cardiac and vascular disease.
  • Multidisciplinary team management is essential for achieving favorable outcomes in these complex cases.